Background: The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) standardized the terminology for indeterminate diagnoses, but the performance of the indeterminate categories before and after TBSRTC has not been compared. This study evaluates the ‘suspicious for a follicular or Hürthle cell neoplasm' (SFN/HCN) category before and after the introduction of TBSRTC at a single institution and in a meta-analysis of the literature. Methods: A meta-analysis compiled findings from publications on SFN/HCN or similar diagnoses before and after the introduction of TBSRTC. The pathology database at our institution identified all SFN/HCN or similar diagnoses in the 8 years surrounding the introduction of TBSRTC, and those cases were correlated with the surgical follow-up. Results: In the meta-analysis, the fraction of cases called SFN/HCN or the equivalent increased from 6.1 to 7.4% (p = 0.0002); the surgical follow-up rate increased from 55 to 61% (p < 0.00001), and the histological malignancy rate among the cases that were resected increased from 22 to 28% (p = 0.03) after TBSRTC. In our institutional experience, the introduction of TBSRTC did not coincide with any significant changes. Conclusion: Standardized terminology clearly coincided with increases in follow-up and the malignancy rate of SFN/HCN. A change in the same statistics was not seen in our institutional experience.

Keywords:
Fine needle aspiration, Thyroid, The Bethesda system for reporting thyroid cytopathology, Suspicious for follicular neoplasm
1.
Li N, Du XL, Reitzel LR, Xu L, Sturgis EM: Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid 2013;23:103-110.
2.
Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2010;19:1167-1214.
3.
Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P: American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract 2010;16:1-43.
4.
Amrikachi M, Ramzy I, Rubenfeld S, Wheeler TM: Accuracy of fine-needle aspiration of thyroid. Arch Pathol Lab Med 2001;125:484-488.
5.
Ali SZ: Thyroid cytopathology: Bethesda and beyond. Acta Cytol 2011;55:4-12.
6.
Cibas ES, Ali SZ: The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009;132:658-665.
7.
Demay RM: Follicular lesions of the thyroid. W(h)ither follicular carcinoma? Am J Clin Pathol 2000;114:681-683.
8.
Olson MT, Clark DP, Erozan YS, Ali SZ: Spectrum of risk of malignancy in subcategories of ‘atypia of undetermined significance'. Acta Cytol 2011;55:518-525.
9.
Olson MT, Tatsas AD, Ali SZ: Cytotechnologist attended on-site adequacy evaluation of thyroid fine needle aspiration: comparison with cytopathologists and correlation with the final interpretation. Am J Clin Pathol 2011;138:90-95.
10.
Gharib H, Goellner JR, Zinsmeister AR, Grant CS, van Heerden JA: Fine-needle aspiration biopsy of the thyroid: the problem of suspicious cytologic findings. Ann Int Med 1984;101:25-28.
11.
Ravetto C, Colombo L, Dottorini ME: Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 2000;90:357-363.
12.
Ko H-M, Jhu I-K, Yang S-H, Lee J-H, Nam J-H, Juhng S-W, Choi C: Clinicopathologic analysis of fine needle aspiration cytology of the thyroid: a review of 1,613 cases and correlation with histopathologic diagnoses. Acta Cytol 2003;47:727-732.
13.
Yang GCH, Liebeskind D, Messina AV: Should cytopathologists stop reporting follicular neoplasms on fine-needle aspiration of the thyroid? Cancer 2003;99:69-74.
14.
Lubitz CC, Faquin WC, Yang J, Mekel M, Gaz RD, Parangi S, Randolph GW, Hodin RA, Stephen AE: Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid 2010;20:25-31.
15.
Wu S, DeMay RM, Papas P, Yan B, Reeves W: Follicular lesions of the thyroid: a retrospective study of 1,348 fine needle aspiration biopsies. Diagn Cytopathol 2010;40:E8-E12.
16.
Seningen JL, Nassar A, Henry MR: Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at mayo clinic, 2001-2007: an institutional experience of 1,945 cases. Diagn Histopathol 2010;40(suppl 1):E27-E32.
17.
Lew JI, Snyder RA, Sanchez YM, Solorzano CC: Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg 2011;213:188-194.
18.
Baloch ZW, Fleisher S, Livolsi VA, Gupta PK: Diagnosis of ‘follicular neoplasm': a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26:41-44.
19.
Renshaw AA: Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol 2001;116:477-482.
20.
Raber W, Kaserer K, Niederle B, Vierhapper H: Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid 2000;10:709-712.
21.
McHenry CR, Thomas SR, Slusarczyk SJ, Khiyami A: Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery 1999;126:798-804.
22.
Schlinkert RT, van Heerden JA, Goellner JR, Gharib H, Smith SL, Rosales RF, Weaver AL: Factors that predict malignant thyroid lesions when fine-needle aspiration is ‘suspicious for follicular neoplasm'. Mayo Clin Proc 1997;72:913-916.
23.
Lin JD, Hsueh C, Chao TC, Weng HF, Huang BY: Thyroid follicular neoplasms diagnosed by high-resolution ultrasonography with fine needle aspiration cytology. Acta Cytol 1997;41:687-691.
24.
Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB: Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery 1994;116:1054-1060.
25.
Kim ES, Nam-Goong IS, Gong G, Hong SJ, Kim WB, Shong YK: Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called ‘follicular neoplasm'. Korean J Intern Med 2003;18:94-97.
26.
Sclabas GM, Staerkel GA, Shapiro SE, Fornage BD, Sherman SI, Vassillopoulou-Sellin R, Lee JE, Evans DB: Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg 2003;186:702-710.
27.
Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z: Does the fine-needle aspiration diagnosis of ‘Hürthle-cell neoplasm/follicular neoplasm with oncocytic features' denote increased risk of malignancy? Diagn Cytopathol 2004;31:307-312.
28.
Miller TR, Abele JS, Greenspan FS: Fine-needle aspiration biopsy in the management of thyroid nodules. West J Med 1981;134:198-205.
29.
Theoharis CGA, Schofield KM, Hammers L, Udelsman R, Chhieng DC: The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 2009;19:1215-1223.
30.
Nayar R, Ivanovic M: The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 national cancer institute thyroid fine needle aspiration state of the science conference. Cancer 2009;117:195-202.
31.
Bongiovanni M, Crippa S, Baloch Z, Piana S, Spitale A, Pagni F, Mazzucchelli L, Di Bella C, Faquin W: Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study. Cancer Cytopathol 2012;120:117-125.
32.
Ustun H, Astarci HM, Altunkaya C, Yilmaz S, Barin A, Ekici S, Caydere M: Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to thyroid Bethesda system. Acta Cytol 2012;56:361-369.
33.
Williams MD, Suliburk JW, Staerkel GA, Busaidy NL, Clayman GL, Evans DB, Perrier ND: Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. Ann Surg Oncol 2009;16:3146-3153.
34.
Faquin WC, Baloch ZW: Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to national cancer institute (NCI) recommendations. Diagn Cytopathol 2010;38:731-739.
35.
Tysome JR, Chandra A, Chang F, Puwanarajah P, Elliott M, Caroll P, Powrie J, Hubbard JG, Clarke SEM, Jeannon JP, Simo R: Improving prediction of malignancy of cytologically indeterminate thyroid nodules. Br J Surg 2009;96:1400-1405.
36.
Schreiner AM, Yang GCH: Adenomatoid nodules are the main cause for discrepant histology in 234 thyroid fine-needle aspirates reported as follicular neoplasm. Diagn Cytopathol 2010;40:375-379.
37.
Jo VY, Stelow EB, Dustin SM, Hanley KZ: Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2010;134:450-456.
38.
Renshaw AA: Should ‘atypical follicular cells' in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol 2010;118:186-189.
39.
Raparia K, Min SK, Mody DR, Anton R, Amrikachi M: Clinical outcomes for ‘suspicious' category in thyroid fine-needle aspiration biopsy: patient's sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med 2009;133:787-790.
40.
Deandrea M, Ragazzoni F, Motta M, Torchio B, Mormile A, Garino F, Magliona G, Gamarra E, Ramunni MJ, Garberoglio R, Limone PP: Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid 2010;20:1077-1083.
41.
Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC: Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid 2011;21:1191-1198.
42.
Wu HH, Rose C, Elsheikh TM: The Bethesda system for reporting thyroid cytopathology: an experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy. Diagn Cytopathol 2011;40:399-403.
43.
Miller B, Burkey S, Lindberg G, Snyder WH III, Nwariaku FE: Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg 2004;188:459-462.
44.
Banks ND, Kowalski J, Tsai HL, Somervell H, Tufano R, Dackiw AP, Marohn MR, Clark DP, Umbricht CB, Zeiger MA: A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 2008;18:933-941.
45.
Mathur A, Moses W, Rahbari R, Khanafshar E, Duh Q-Y, Clark O, Kebebew E: Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer 2011;117:4390-4395.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.